Medix-Asia

Medix-Asia To enable people around the world to receive the best medical care possible and to make a real difference in their lives

作為一間開創性的全球醫療健康管理公司，Medix會充分發揮專業的健康和醫療知識、治療和科技的潛力，以滿足人們最關鍵的需求。
---
Medix is a groundbreaking global health management company engineered to direct the full potential of health and medical expertise, treatment, & technology to people's most critical needs.

荷爾蒙健康絕非『小眾』的女性議題。它可影響生育能力、工作效率、精神健康，以及未來的勞動力市場。值此國際婦女節之際，我們將聚焦生物學與職場設計的碰撞，並探討為何真正的公平意味著：透過符合現實而非過時規範的制度，支援女性度過多囊卵巢症候群、子宮...
10/03/2026

荷爾蒙健康絕非『小眾』的女性議題。它可影響生育能力、工作效率、精神健康，以及未來的勞動力市場。值此國際婦女節之際，我們將聚焦生物學與職場設計的碰撞，並探討為何真正的公平意味著：透過符合現實而非過時規範的制度，支援女性度過多囊卵巢症候群、子宮內膜異位症、生育歷程、懷孕及產後恢復等階段。公平的經濟體系不應迫使女性在健康、家庭與事業間作出抉擇。

---------------------------------------------------------------------

Hormonal health is not a “niche” women’s issue — it shapes fertility, productivity, mental health, and the future workforce. This Women’s Day week, we’re spotlighting how biology and workplace design collide, and why real equity means supporting women through PCOS, endometriosis, fertility journeys, pregnancy, and postpartum with structures that match reality, not outdated norms. A fair economy should never ask women to choose between health, family, and career.

02/03/2026

多囊卵巢症候群不只是卵巢、月經或生育的問題。
它是一種代謝與炎症的疾病——深受胰島素阻抗、壓力、內臟脂肪與荷爾蒙訊號傳導的影響。
長久以來，女性只被要求減重或服用避孕藥。
現在的科學告訴我們不同的故事：改善胰島素敏感性、處理慢性壓力、降低炎症及應，並提供個人化護理。
多囊卵巢症候群不代表是敗於意志力。
這是一種系統層級的狀況，需要指對其系統的醫療。

--------------------------------------------------------------------------------

PCOS is not just about ovaries, periods, or fertility.

It is a metabolic and inflammatory condition — deeply influenced by insulin resistance, stress, visceral fat, and hormonal signaling.

For too long, women were told to lose weight or go on the pill.
The science now tells a different story: treat insulin sensitivity, address chronic stress, reduce inflammation, and personalise care.

PCOS is not a failure of willpower.
It’s a system‑level condition that deserves system‑level medicine.

25/02/2026

罕見疾病雖然各自不常見，但總計影響全球 3% 至 6% 的人口，牽涉數以百萬計的生命。
每一個漫長確診過程的背後，不單是醫療上的複雜性，還有分散的醫療系統、有限的專家接觸以及不符合教科書定義的症狀。
在 Medix Global，我們致力透過人工智能表型分析、跨學科專家覆核、統籌快速診斷，以及連繫全球專家網絡，來縮短這一趟旅程。因為及早確診能改變結果。

我們重視你的意見，你認為需要改變甚麼才可縮短這段確診長征？

----------------------------------------------------------------------------------------

Rare diseases may be individually uncommon, but together they affect 3–6% of the global population, representing millions of lives worldwide.
Behind every prolonged diagnosis is more than medical complexity. It’s fragmented systems, limited access to specialists, and symptoms that don’t fit neatly into textbook definitions.
At Medix Global, we focus on shortening that journey through AI-powered phenotyping, multidisciplinary expert review, coordinated rapid diagnostics, and access to a global network of specialists.
Because earlier clarity changes outcomes.
We’d value your perspective - what needs to change to reduce the diagnostic odyssey?

罕見疾病雖個別不常見，但總體影響全球3–6%人口，涉及數百萬生命。每項延宕的診斷背後，不僅是醫學複雜性。更源於系統碎片化、專科資源匱乏，以及難以套用教科書定義的症狀。在Medix Global，我們致力於透過人工智能驅動的表型分析、跨領域專...
25/02/2026

罕見疾病雖個別不常見，但總體影響全球3–6%人口，涉及數百萬生命。

每項延宕的診斷背後，不僅是醫學複雜性。更源於系統碎片化、專科資源匱乏，以及難以套用教科書定義的症狀。

在Medix Global，我們致力於透過人工智能驅動的表型分析、跨領域專家審查、協調式快速診斷，以及全球專家網絡的接入，縮短診斷之路。

因為更早的清晰診斷，改變治療結果。

我們誠摯邀請您分享見解：哪些變革能有效縮短這段診斷漫遊之旅？

--------------------------------------------------------------------------

Rare diseases may be individually uncommon, but together they affect 3–6% of the global population, representing millions of lives worldwide.

Behind every prolonged diagnosis is more than medical complexity. It’s fragmented systems, limited access to specialists, and symptoms that don’t fit neatly into textbook definitions.

At Medix Global, we focus on shortening that journey, through AI-powered phenotyping, multidisciplinary expert review, coordinated rapid diagnostics, and access to a global network of specialists.

Because earlier clarity changes outcomes.

We’d value your perspective on what needs to change to reduce the diagnostic odyssey.

Medix祝你馬年大吉、馬歲安康、馬運亨通！願我們來年一起馬力全開、馬年行大運！--------------------------------------------Wishing you a prosperous Year of the...
17/02/2026

Medix祝你馬年大吉、馬歲安康、馬運亨通！

願我們來年一起馬力全開、馬年行大運！

--------------------------------------------

Wishing you a prosperous Year of the Horse - full of momentum, growth, and forward motion.
Here’s to bold moves and meaningful wins.
Happy Lunar New Year!

儘管腦癇症照護正邁入新紀元，從VIMPAT等先進藥物，到FDA核准的穿戴裝置、AI驅動的癲癇發作預測、精準的影像掃描技術，再到神經刺激療法及微創手術等，高達70%的腦癇症患者可透過適切治療實現無發作狀態；然而，治療的可及性與個人化仍是關鍵所...
09/02/2026

儘管腦癇症照護正邁入新紀元，從VIMPAT等先進藥物，到FDA核准的穿戴裝置、AI驅動的癲癇發作預測、精準的影像掃描技術，再到神經刺激療法及微創手術等，高達70%的腦癇症患者可透過適切治療實現無發作狀態；然而，治療的可及性與個人化仍是關鍵所在。值此國際腦癇日，讓我們透過提升認知締造更佳醫學成果。

------------------------------------------------------------------------------

Epilepsy care is entering a new era — from advanced medications like VIMPAT, to FDA‐cleared wearables, AI‐driven seizure forecasting, precision imaging, neurostimulation, and minimally invasive surgery. Up to 70% of people with epilepsy could become seizure‐free with the right treatment — yet access and personalization still matter. On World Epilepsy Day, let’s turn awareness into better outcomes.

06/02/2026

當 Francis 意外確診癌症時，恐懼不僅來自治療本身，更源於對癌細胞是否已擴散的未知。

為尋求明確答案與安心保障，他選擇了Medix。

「我感受到Medix待我如摯友，如家人⋯⋯」

透過專業醫療評估與溫情關懷，恐懼逐漸轉化為確切答案，不確定性也化為希望曙光。

值此世界癌症日，Francis的故事提醒我們：沒有人應孤獨面對癌症。

觀看他的分享影片，見證Medix帶來的改變。

----------------------------------------------------------------------------------------------------

When Francis Cheuk received an unexpected cancer diagnosis, the fear wasn’t just about treatment - it was about not knowing if the cancer had spread.

Searching for clarity and reassurance, he turned to Medix.

“I felt that Medix treated me like a friend, like family…”

Through expert medical review and compassionate support, fear gave way to answers — and uncertainty to hope.

This World Cancer Day Week, Francis’s story reminds us that no one should face cancer alone.

Watch his testimonial to see how Medix made the difference.

關於癌症的最常見誤解之一是它總由疼痛開始。然而，事實上許多早期徵狀都是非常細微且容易被忽視的。例如相對更容易疲倦；身體出現持續性轉變；感覺輕微異常但又不欲立即行動等。由於沒有疼痛，人們往往會選擇拖延。但早期介入並不代表臆測或悲觀，而是為了獲...
05/02/2026

關於癌症的最常見誤解之一是它總由疼痛開始。然而，事實上許多早期徵狀都是非常細微且容易被忽視的。例如相對更容易疲倦；身體出現持續性轉變；感覺輕微異常但又不欲立即行動等。
由於沒有疼痛，人們往往會選擇拖延。但早期介入並不代表臆測或悲觀，而是為了獲得準確信息，以便冷靜且有效地採取行動。值此世界癌症日之際，我們希望簡單提醒大家：及早聆聽身體的聲音，對自己未來的健康發展至關重要。
💬 如果這文章改變了你對早期發現的重要性，請留言「關注」。
🔁 分享這篇文章，一個動作幫助大眾及時採取行動。
💾 儲存這篇文章，提醒自己不要忽略持續性的身體變化。

---------------------------------------------------------------------------------

One of the most common myths about cancer is that it always starts with pain. In reality, many early signs are subtle — and easy to ignore. A little more tired than usual. A change that doesn’t go away. Something that feels “off,” but not serious enough to act on. Because there’s no pain, people often wait. But early evaluation isn’t about assuming the worst. It’s about gaining clarity — early enough to act calmly and effectively. This World Cancer Day, the reminder is simple:
listening to your body early can make a real difference later.
💬 Comment “Aware” if this changed how you think about early signs.
🔁 Share this post — it could help someone take action in time.
💾 Save this as a reminder to not ignore persistent changes.


#世界癌症日 #癌症防治 #抗癌 #健康意识 #早期筛查

甲狀腺疾病經常被誤診，並非因其罕見，而是因其複雜性。全球範圍內，甲狀腺功能減退與亢進常常會因症狀重疊而被漏診；然而在高收入國家的女性甲狀腺癌病例中，估計有高達50-90%被過度診斷。2013至2017年間，全球有逾170萬例甲狀腺癌診斷可能...
23/01/2026

甲狀腺疾病經常被誤診，並非因其罕見，而是因其複雜性。

全球範圍內，甲狀腺功能減退與亢進常常會因症狀重疊而被漏診；然而在高收入國家的女性甲狀腺癌病例中，估計有高達50-90%被過度診斷。

2013至2017年間，全球有逾170萬例甲狀腺癌診斷可能屬於過度診斷。儘管確診率攀升，死亡率卻基本持平，凸顯單次檢測與倉促臨床決策的潛在風險。

全面的评估、持续的监测和专家的医疗意见有助于获得更好的治疗效果。

Medix取得的成果：
* 18.5% 修正診斷
* 54% 調整或優化治療
* 27 % 避免不必要的治療、醫療程序或手術

-------------------------------------------------------------------

Thyroid disorders are often misunderstood, not because they’re rare, but because they’re complex.

Globally, hypo- and hyperthyroidism are frequently missed due to overlapping symptoms, while up to 50–90% of thyroid cancers in women in high-income countries are estimated to be over-diagnosed.

Between 2013–2017, over 1.7 million thyroid cancer diagnoses worldwide may represent overdiagnosis. Despite rising diagnoses, mortality has remained largely unchanged, underscoring the risks of one-time testing and rushed clinical decisions.

Better outcomes come from integrated review, longitudinal follow-up, and informed opinions.

Medix outcomes achieved:
* Change in diagnosis: 18.5 %
* Change or optimization of treatment: 54%
* Avoidance of unnecessary treatments, procedures, or surgeries: 27%

Address

Hong Kong

Telephone

+85238960500

Website

Alerts

Be the first to know and let us send you an email when Medix-Asia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Medix-Asia:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category